Although hyperinsulinaemia and insulin resistance in post-menopausal women are associated with higher risk of ER + breast cancer subtypes [9, 32], use of exogenous glucocorticoids has been associated with lower risk of ER + PR + subtypes [33]. The gene discussed is PGR; the disease is breast cancer.